STOCK TITAN

Optinose to Present at the 2023 Cantor Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Optinose to present at Cantor Global Healthcare Conference
Positive
  • None.
Negative
  • None.

YARDLEY, Pa., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the 2023 Cantor Global Healthcare Conference on September 27, 2023 at 4:45 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531


OptiNose, Inc.

NASDAQ:OPTN

OPTN Rankings

OPTN Latest News

OPTN Stock Data

102.18M
150.78M
5.99%
77.38%
5.76%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
YARDLEY